- Home
- SLRN vs GAIN Comparison
SLRN vs GAIN Comparison
Compare SLRN & GAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRN
- GAIN
- Stock Information
- Founded
- SLRN 2020
- GAIN 2005
- Country
- SLRN United States
- GAIN United States
- Employees
- SLRN N/A
- GAIN N/A
- Industry
- SLRN Biotechnology: Pharmaceutical Preparations
- GAIN Finance: Consumer Services
- Sector
- SLRN Health Care
- GAIN Finance
- Exchange
- SLRN Nasdaq
- GAIN Nasdaq
- Market Cap
- SLRN 485.6M
- GAIN 473.7M
- IPO Year
- SLRN 2023
- GAIN 2005
- Fundamental
- Price
- SLRN $4.35
- GAIN $13.46
- Analyst Decision
- SLRN Buy
- GAIN Hold
- Analyst Count
- SLRN 6
- GAIN 2
- Target Price
- SLRN $11.50
- GAIN $13.75
- AVG Volume (30 Days)
- SLRN 463.0K
- GAIN 123.4K
- Earning Date
- SLRN 11-13-2024
- GAIN 11-07-2024
- Dividend Yield
- SLRN N/A
- GAIN 7.11%
- EPS Growth
- SLRN N/A
- GAIN N/A
- EPS
- SLRN N/A
- GAIN 1.06
- Revenue
- SLRN N/A
- GAIN $91,472,000.00
- Revenue This Year
- SLRN N/A
- GAIN $6.61
- Revenue Next Year
- SLRN N/A
- GAIN $0.83
- P/E Ratio
- SLRN N/A
- GAIN $12.72
- Revenue Growth
- SLRN N/A
- GAIN 11.51
- 52 Week Low
- SLRN $3.36
- GAIN $12.46
- 52 Week High
- SLRN $8.89
- GAIN $14.96
- Technical
- Relative Strength Index (RSI)
- SLRN 31.17
- GAIN 45.98
- Support Level
- SLRN $4.29
- GAIN $13.45
- Resistance Level
- SLRN $6.19
- GAIN $13.94
- Average True Range (ATR)
- SLRN 0.45
- GAIN 0.26
- MACD
- SLRN -0.20
- GAIN -0.01
- Stochastic Oscillator
- SLRN 6.39
- GAIN 53.37
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of of transformative medicines.
About GAIN Gladstone Investment Corporation Business Development Company
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to (i) achieve and grow current income by investing in debt securities of established businesses. (ii) provide our stockholders with long-term capital appreciation in the value of our assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.